Αποτελέσματα Αναζήτησης
Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis
juvenile arthritis is juvenile idiopathic arthritis (JIA). JIA has also been referred to as juvenile rheumatoid arthritis. However, juvenile idiopathic arthritis is the term most preferred globally by medical professionals. The major symptoms for most forms of arthritis are pain, fatigue and stiffness and swelling in one or more joints.
Juvenile idiopathic arthritis (JIA) is the most common pediatric rheumatic disease that affects teens and children under the age of 16. Rheumatic diseases affect the mus-culoskeletal system (joints, ligaments, tendons, bones, muscles, cartilage, connective tissue).
Onel KB, Shenoi S. 2021 American College of Rheumatology guideline for the treatment of juvenile idiopathic arthritis (JIA): therapeutic approaches for oligoarthritis, temporomandibular joint arthritis (TMJ), and systemic JIA, medication monitoring, immunizations and non-pharmacologic therapies.
Juvenile idiopathic arthritis (JIA) unifies all forms of chronic childhood arthritis, affecting not only joints, but extra-articular structures, including eyes, skin, and in-ternal organs, leading to disability and even associated fatality.
The term juvenile idiopathic arthritis (JIA) defines a heterogeneous collection of inflammatory arthritides of unknown etiology with onset prior to age 16 years and a minimum dura-
Juvenile rheumatoid arthritis (JRA) is arbi trarily defined as RA beginning before the age of 16. It rarely begins before six months of age, and most cases appear between the ages of one and three with a second peak at 8-12 years of age.
